Inventor · disambiguated record
Philip E. Thorpe
Also filed as: THORPE PHILIP · THORPE PHILIP E
66 granted patents·17 pending applications·7,124 citations·filing 1987–2016
99Inventor score
Files withUNIV TEXAS69THORPE PHILIP E6ICRF PATENTS LIMITED2SCRIPPS RESEARCH INST2IMP CANCER RES TECH1
Top patents by PatentIndex Score
83 records- 0199US6703020B1Antibody conjugate methods for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Mar 9, 2004·296 cites·49 claims
- 0299US6524583B1Antibody methods for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Feb 25, 2003·215 cites·40 claims
- 0399US6342221B1Antibody conjugate compositions for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Jan 29, 2002·354 cites·68 claims
- 0499US6342219B1Antibody compositions for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Jan 29, 2002·651 cites·50 claims
- 0599US6051230ACompositions for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1995·Granted Apr 18, 2000·406 cites·61 claims
- 0698US7125541B2Combined methods for tumor vasculature targeting and tumor treatment with radiotherapyUNIV TEXAS·Filed 2000·Granted Oct 24, 2006·86 cites·15 claims
- 0798US6783760B1Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 2001·Granted Aug 31, 2004·87 cites·54 claims
- 0898US6676941B2Antibody conjugate formulations for selectively inhibiting VEGFUNIV TEXAS·Filed 2001·Granted Jan 13, 2004·144 cites·68 claims
- 0998US6416758B1Antibody conjugate kits for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Jul 9, 2002·153 cites·50 claims
- 1098US6312694B1Cancer treatment methods using therapeutic conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 1999·Granted Nov 6, 2001·233 cites·50 claims
- 1198US6261535B1Diagnostic methods for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1998·Granted Jul 17, 2001·209 cites·27 claims
- 1298US5877289ATissue factor compositions and ligands for the specific coagulation of vasculatureSCRIPPS RESEARCH INST·Filed 1995·Granted Mar 2, 1999·310 cites·100 claims
- 1398US5863538ACompositions for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1995·Granted Jan 26, 1999·206 cites·23 claims
- 1498US5855866AMethods for treating the vasculature of solid tumorsUNIV TEXAS·Filed 1994·Granted Jan 5, 1999·469 cites·26 claims
- 1598US5776427AMethods for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1995·Granted Jul 7, 1998·379 cites·23 claims
- 1698US5660827AAntibodies that bind to endoglinUNIV TEXAS·Filed 1995·Granted Aug 26, 1997·299 cites·30 claims
- 1798US4880935AHeterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoatesICRF PATENTS LIMITED·Filed 1987·Granted Nov 14, 1989·328 cites·4 claims
- 1897US7056509B2Antibody methods for selectively inhibiting VEGFUNIV TEXAS·Filed 2003·Granted Jun 6, 2006·77 cites·22 claims
- 1997US6004555AMethods for the specific coagulation of vasculatureUNIV TEXAS·Filed 1995·Granted Dec 21, 1999·210 cites·87 claims
- 2097US5965132AMethods and compositions for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1994·Granted Oct 12, 1999·171 cites·16 claims
- 2196US7112317B2Combined methods and compositions for tumor vasculature targeting and tumor treatmentUNIV TEXAS·Filed 2003·Granted Sep 26, 2006·47 cites·14 claims
- 2296US6887468B1Antibody kits for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted May 3, 2005·70 cites·55 claims
- 2396US6093399AMethods and compositions for the specific coagulation of vasculatureUNIV TEXAS·Filed 1995·Granted Jul 25, 2000·174 cites·103 claims
- 2495US6749853B1Combined methods and compositions for coagulation and tumor treatmentUNIV TEXAS·Filed 2000·Granted Jun 15, 2004·40 cites·47 claims
- 2595US6406693B1Cancer treatment methods using antibodies to aminophospholipidsUNIV TEXAS·Filed 1999·Granted Jun 18, 2002·141 cites·63 claims
- 2695US6036955AKits and methods for the specific coagulation of vasculatureSCRIPPS RESEARCH INST·Filed 1995·Granted Mar 14, 2000·148 cites·102 claims
- 2794US7691380B2Combined methods for tumor coagulation and tumor treatmentUNIV TEXAS·Filed 2003·Granted Apr 6, 2010·39 cites·69 claims
- 2894US6818213B1Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 1999·Granted Nov 16, 2004·95 cites·64 claims
- 2994US6004554AMethods for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1993·Granted Dec 21, 1999·129 cites·24 claims
- 3093US7455833B2Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipidsUNIV TEXAS·Filed 2003·Granted Nov 25, 2008·39 cites·118 claims
- 3193US5762918AMethods of using steroid-polyanionic polymer-based conjugated targeted to vascular endothelial cellsUNIV TEXAS·Filed 1993·Granted Jun 9, 1998·119 cites·25 claims
- 3292US9835626B2Methods and compositions for isolating exosomesUNIV TEXAS·Filed 2015·Granted Dec 5, 2017·14 cites·50 claims
- 3392US7422738B2Combined cancer treatment methods using antibodies to aminophospholipidsUNIV TEXAS·Filed 2001·Granted Sep 9, 2008·34 cites·53 claims
- 3492US7067109B1Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 1999·Granted Jun 27, 2006·57 cites·35 claims
- 3592US6156321ATissue factor methods and compositions for coagulation and tumor treatmentUNIV TEXAS·Filed 1998·Granted Dec 5, 2000·123 cites·47 claims
- 3692US5474765APreparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cellsUT SW MEDICAL CTR AT DALLAS·Filed 1992·Granted Dec 12, 1995·125 cites·24 claims
- 3791US8486391B2Cancer treatment kits using antibodies to aminophospholipidsTHORPE PHILIP E·Filed 2006·Granted Jul 16, 2013·8 cites·35 claims
- 3891US7790860B2Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 2009·Granted Sep 7, 2010·15 cites·15 claims
- 3991US7611704B2Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipidsUNIV TEXAS·Filed 2003·Granted Nov 3, 2009·31 cites·205 claims
- 4091US7247303B2Selected antibody CDRs for binding to aminophospholipidsUNIV TEXAS·Filed 2003·Granted Jul 24, 2007·34 cites·21 claims
- 4191US6451312B1VEGF-gelonin for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1999·Granted Sep 17, 2002·45 cites·19 claims
- 4290US8709430B2Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipidsTHORPE PHILIP E·Filed 2005·Granted Apr 29, 2014·5 cites·32 claims
- 4389US8653034B2Compositions and methods comprising phosphatidylethanolamine-binding peptide derivativesTHORPE PHILIP E·Filed 2008·Granted Feb 18, 2014·4 cites·29 claims
- 4489US7976868B2Liposomes comprising duramycin and anti-viral agentsUNIV TEXAS·Filed 2010·Granted Jul 12, 2011·5 cites·13 claims
- 4589US6132729ACombined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatmentUNIV TEXAS·Filed 1998·Granted Oct 17, 2000·60 cites·46 claims
- 4688US7550141B2Methods for imaging tumor vasculature using conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 2004·Granted Jun 23, 2009·12 cites·20 claims
- 4788US6132730ACombined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatmentUNIV TEXAS·Filed 1998·Granted Oct 17, 2000·54 cites·31 claims
- 4886US7572448B2Combined cancer treatment methods using selected antibodies to aminophospholipidsUNIV TEXAS·Filed 2003·Granted Aug 11, 2009·13 cites·73 claims
- 4984US8956616B2Constructs binding to phosphatidylserine and their use in disease treatmentTHORPE PHILIP E·Filed 2006·Granted Feb 17, 2015·10 cites·31 claims
- 5083US7378386B2Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivativesUNIV TEXAS·Filed 2003·Granted May 27, 2008·9 cites·77 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Philip E. Thorpe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →